Pain Therapeutics reported $17.82M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8983M 107M
Acelrx Pharmaceuticals ACRX:US $ 9.44M 1.26M
Acura Pharmaceuticals ACUR:US 913K 123K
Amgen AMGN:US $ 3.74B 804M
Biogen BIIB:US $ 1921.1M 225.6M
Cara Therapeutics CARA:US $ 32.7M 1.64M
Eisai 4523:JP Y 211704M 22380M
Eli Lilly And LLY:US $ 5405.7M 677M
Geron GERN:US $ 28.8M 3.22M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Merk MRK:US $ 10332M 386M
Novartis NOVN:VX 9.96B 998M
Novavax NVAX:US $ 494.68M 552.49M
Pain Therapeutics PTIE:US $ 17.82M 3.38M
Pfizer PFE:US $ 15788M 3271M